$65.18
▲ +$0.40
(+0.62%)
Vol 570K
4
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$3.0B
ROE
-31.6%
D/E
5.05
Beta
0.88
52W
$31–$100
Wall Street Consensus
19 analysts · Apr 20267
Strong Buy
11
Buy
1
Hold
0
Sell
0
Strong Sell
94.7%
Buy Rating
Price Chart
Similar Stocks
TVTX
Travere Therapeutics Inc
$3.4B
ORKA
Oruka Therapeutics Inc
$1.5B
VCYT
Veracyte Inc
P/E 110.3
$3.3B
BEAM
Beam Therapeutics Inc
$2.8B
KOD
Kodiak Sciences Inc
$1.7B
IMNM
Immunome Inc
$2.4B
SRPT
Sarepta Therapeutics Inc
$2.3B
BCRX
BioCryst Pharmaceuticals Inc
$1.6B
GRAL
Grail Inc
$3.3B
RLAY
Relay Therapeutics Inc
$1.5B
Earnings
Beat rate: 50.0%| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Dec 2025 | $-1.78 | $-1.64 | +$0.14 |
| Sep 2025 | $-1.49 | $-1.77 | $-0.28 |
| Jun 2025 | $-1.18 | $-1.58 | $-0.40 |
| Mar 2025 | $-1.16 | $-1.02 | +$0.14 |
Quarterly Revenue & Earnings
| Quarter | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… | 2025-1… |
|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — |
| Net Income | — | -$29.5M | -$34.1M | -$55.2M | -$62.3M | -$60.5M |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -26.6% | -26.6% | -26.6% | -26.6% | -31.6% | -31.6% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | 4.68 | 4.68 | 4.68 | 4.68 | 5.05 | 5.05 |
| Current Ratio | 32.11 | 32.11 | 32.11 | 32.11 | 23.45 | 23.45 |
Key Ratios
ROA (TTM)
-29.0%
P/B
4.2
EPS (TTM)
$-5.35
CF/Share
$-3.60
52W High
$99.50
52W Low
$30.82
$30.82
52-Week Range
$99.50
Financial Health
Free Cash Flow
-$43.3M
Net Debt
-$60.1M
Cash
$91.1M
Total Debt
$31.0M
As of Dec 31, 2025
How does IRON compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
IRON valuation vs Biotechnology peers
P/E ratio
—
▼
0%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
—
▼
0%
below
peers
(12.9)
vs Peers
vs Industry
Overvalued
P/B ratio
4.3
▲
73%
above
peers
(2.5)
vs Peers
vs Industry
Overvalued
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
IRON profitability vs Biotechnology peers
ROE
-31.6%
▲
53%
above
peers
(-67.3%)
vs Peers
vs Industry
Top tier
Net margin
—
▼
0%
below
peers
(-286.8%)
vs Peers
vs Industry
Top tier
Gross margin
—
▼
0%
below
peers
(78.6%)
vs Peers
vs Industry
In line
ROA
-29.0%
▲
38%
above
peers
(-46.7%)
vs Peers
vs Industry
Below avg
IRON financial health vs Biotechnology peers
D/E ratio
5.1
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
High debt
Current ratio
23.5
▲
428%
above
peers
(4.4)
vs Peers
vs Industry
Strong liquidity
Beta
0.9
▼
10%
below
peers
(1.0)
vs Peers
vs Industry
Less volatile
IRON fundamentals radar
IRON
Peer median
Industry
IRON profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
IRON vs peers: key metrics
Insider Activity
NeutralBuys
0
Sells
0
SAVAGE WILLIAM JACOB
Officer · Mar 02
7378 shs
FRANCHI JEAN M
Chief Financial Officer · Feb 25
353 shs
FRANCHI JEAN M
Chief Financial Officer · Feb 18
11156 shs
QUISEL JOHN D
Chief Executive Officer · Feb 17
13264 shs
STEPHENSON PAMELA
Officer · Feb 17
5531 shs
YU JONATHAN YEN-WEN
Chief Operating Officer · Feb 17
3231 shs
SAVAGE WILLIAM JACOB
Officer · Feb 17
3256 shs
KHARA RAHUL
Officer · Feb 17
2853 shs
QUISEL JOHN D
Chief Executive Officer · Feb 10
55200 shs
FRANCHI JEAN M
Chief Financial Officer · Feb 10
19000 shs
Last 90 days
Top Holders
Top 5: 34.5%FMR, LLC
14.28%
$329.6M
Blackrock Inc.
5.96%
$137.6M
RA Capital Management, L.P.
5.18%
$119.5M
Vanguard Group Inc
4.63%
$106.9M
Price (T.Rowe) Associates I…
4.45%
$102.7M
As of Dec 31, 2025